Skip to content

Significance of intraoperative use of pseudomonas aeruginosa injection for rapid recovery postoperative in thyroid cancer patients with lymph node dissection -- a randomized controlled study

Significance of intraoperative use of pseudomonas aeruginosa injection for rapid recovery postoperative in thyroid cancer patients with lymph node dissection -- a randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010605
Enrollment
Unknown
Registered
2017-02-09
Start date
2017-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

A:Intraoperative use of pseudomonas aeruginosa injection(Unilaterality 2 ml,Bilaterality 4 ml)
B:Intraoperative don't use of pseudomonas aeruginosa injection

Sponsors

Thyroid and Parathyroid Surgery Center, West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with age between 18-80 years; 2. Sign the informed consent; 3. thyroid cancer patients with lateral lymph nodes dissection; 4. American Society of Anesthesiologists (ASA) scoring of 1 to 2.

Exclusion criteria

Exclusion criteria: 1. There is a clear history of allergy; 2. Unwillingness to participate.

Design outcomes

Primary

MeasureTime frame
length of stay postoperation;the total medical costs;Daily volume of drainage;Triglyceride levels (drainage liquid);Thyroglobulin levels;Red blood cell count (drainage liquid);

Secondary

MeasureTime frame
Daily body temperature;The score wound pain;Leucocyte levels;condition of wound;

Countries

China

Contacts

Public ContactJingqing Zhu

Thyroid and Parathyroid Surgery Center, West China Hospital of Sichuan University

zjq-wkys@163.com+86 028-85422467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026